Education Blog for Healthcare Professionals

TTP with I.V. Use of Pain Medication OpanaER

Stephan Moll, MD writes… 

The CDC published an alert on Oct 26th, 2012, that they are investigating 12 cases of TTP (thrombotic thrombocytopenic purpura) in drug users who injected intravenously the opioid pain medication Opana ER® (oxymorphone extended-release), a medication made as a tablet and meant for oral use. The tablet was pulverized by the drug users to allow i.v. injection (detailed CDC alert here). 

Relevance for clinicans involved in the care of patients with TTP:  Inquire in the history taking about drug abuse and injection of Opana ER.

Last updated: Oct 29th, 2012

 

Tags: , , , ,

This entry was posted by Clot Connect on at and is filed under Clots in unusual locations, Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.